Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company that is on a mission to enable independent pharmacies to operate
Trxade explores alternative ways to find partners for B2C assets: CEO Suren Ajjarapu
Categories
Healthcare Technology
Earnings: Trxade Health (MEDS) reports 6% drop in Q3 revenue; loss narrows
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a modest decline in its third-quarter revenues. Meanwhile, the company's
Why AngioDynamics (ANGO) deserves a place on investors’ watchlist
The market reopening has created a conducive atmosphere to carry out elective medical procedures which were deferred on a large scale during
Trxade Health Inc. (NASDAQ: MEDS) Q3 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is an integrated drug delivery platform that offers a digitalized retail pharmacy experience to independent pharmacies, allowing
Trxade will focus more on core biz, connect with POS systems: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) has been on a mission to digitalize the retail pharmacy experience by providing a platform for independent
MEDS Earnings: Trxade Health Q2 revenues surge 73% amid continued user growth
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a sharp increase in its second-quarter 2022 revenues. The top
Trxade Health Inc. (NASDAQ: MEDS) Q1 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It helps independent
Trxade will stay focused on traditional technology platform for margin growth: CEO Suren Ajjarapu
[caption id="attachment_135351" align="alignnone" width="1280"] Image: iStock[/caption] Can you briefly talk about your business model and the value you add to the market?
Trxade Health Inc. (NASDAQ: MEDS) Q4 2021 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare service technology platform that mainly serves the secondary pharmaceutical supply chain, offering a web-based
Champions Oncology, Inc. (CSBR) Q2 2022 Earnings Call Transcript
Champions Oncology, Inc. (NASDAQ: CSBR) Q2 2022 earnings call dated Dec. 13, 2021. Corporate Participants: Ronnie Morris -- President & Chief Executive Officer David
Trxade CEO Suren Ajjarapu: Will see the impact of GPO program by Q3 next year
Image: iStock Give us a quick overview of the company. Trxade is a market platform that caters to the independent pharmacies that
Trxade Health beats on Q3 revenue estimate
Trxade Health Inc (NASDAQ: MEDS) on Monday posted third-quarter revenues of $2.6 million, down year-over-over as a result of non-recurring PPE sales.
IPO News: What to look for when Healthcare Triangle goes public
The global healthcare information technology market was valued at $74.2 billion in 2020, and it is expected to grow at a compound
iFIT Health & Fitness to raise $600 mln in IPO. Here’s what you need to know
The technology and healthcare industries have dominated the IPO market in the recent past, but it seems the spotlight is shifting to
Trxade Health Inc. (NASDAQ: MEDS) Q3 2021 Research Summary
It is estimated that the North American e-Pharmacy market would grow at a compound annual rate of 14.8% through 2025. In the